Selecting empiric therapy is becoming increasingly complex and often leads to over or under-treatment. Either can negatively impact patient outcomes, with a possible increase in mortality and antimicrobial resistance in the long term.

The European Accreditation Council for Continuing Medical Education (EACCME®) has accredited the session with 1 European CME credit (ECMEC®).

The replay is now available on the ESICM Academy. You need to be an ESICM member to connect.

Learning Outcomes

• Be aware of molecular rapid identification methods existing.
• Understand what patients will benefit from Rapid Multiplex PCR.
• Understand how to use the results of these tests and act on the anti-infective management of these patients.

Experts

Romain SONNEVILLE
Bichat Claude Bernard University Hospital, Université Paris Cité (FR). 

Etienne DE MONTMOLLIN
Nantes University Hospital (FR).

Moderator
Matthias KLEIN
LMU Klinikum, Ludwig Maximilians University Munich (DE).